Screening for hearing loss in an at-risk neonatal population using evoked otoacoustic emissions.
The present study examines the performance of a transient evoked otoacoustic emissions hearing screening programme for neonates with risk factors for hearing loss. The programme has run for 5 years, and 772 babies with various risk factors have been screened using the Programmable Otoacoustic Emissions Measurement System (POEMS) designed by the Medical Research Council Institute of Hearing Research. Fourteen cases of significant hearing loss have been detected, with no false negative results. However, a very high false positive rate is reported, especially in babies with a birthweight of less than 1500 g.
Meredith
R
R
Welsh Hearing Institute, University Hospital of Wales, Cardiff, UK.
Stephens
D
D
Hogan
S
S
Cartlidge
P H
PH
Drayton
M
M
D003051:Cochlea / Q000502:physiology*; D004558:Electric Stimulation; D005865:Gestational Age; D006314:Hearing Loss, Conductive / Q000175:diagnosis*; D006319:Hearing Loss, Sensorineural / Q000175:diagnosis*; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D015997:Neonatal Screening